Literature DB >> 14998982

In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.

A Athamna1, M Athamna, B Medlej, D J Bast, E Rubinstein.   

Abstract

OBJECTIVES: The aim of this study was to investigate in vitro the post-antibiotic effect (PAE) of 19 antibacterial agents against two strains of Bacillus anthracis (ST-1 and Sterne strains).
METHODS: PAE was determined by calculating the time required for the viable counts of antibiotic-exposed bacteria (at concentrations of 10x MIC and exposure for 2 h) at 37 degrees C to increase by 1 log10 above the counts observed immediately after antibiotic removal compared with the corresponding time for controls not exposed to antibiotics.
RESULTS: The PAEs of the fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin and garenoxacin) were 2-5 h. The macrolide (erythromycin, clarithromycin and telithromycin) PAEs were 1-4 h, and that of clindamycin was 2 h. The PAEs induced by tetracycline and minocycline were 1-3 h. The PAEs induced by the beta-lactams (penicillin G, amoxicillin and ceftriaxone), vancomycin, linezolid and chloramphenicol were 1-2 h. The PAE induced by rifampicin was 4-5 h. Quinupristin/dalfopristin had the longest PAE, lasting for 7-8 h.
CONCLUSIONS: Our results indicate that the PAE is unrelated to the MIC but may be related to the rapidity of bacterial kill. These observations may bear importance on treatment regimens of human anthrax.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998982     DOI: 10.1093/jac/dkh130

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Arrested protein synthesis increases persister-like cell formation.

Authors:  Brian W Kwan; John A Valenta; Michael J Benedik; Thomas K Wood
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

Review 2.  Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.

Authors:  Mitsushige Sugimoto; Takahisa Furuta
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pylori.

Authors:  Hyun Chul Lim; Yong Jae Lee; Byoungrak An; Seung Woo Lee; Yong Chan Lee; Byung Soo Moon
Journal:  Helicobacter       Date:  2014-09-18       Impact factor: 5.753

4.  Drug detoxification dynamics explain the postantibiotic effect.

Authors:  Jaydeep K Srimani; Shuqiang Huang; Allison J Lopatkin; Lingchong You
Journal:  Mol Syst Biol       Date:  2017-10-23       Impact factor: 11.429

5.  Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic.

Authors:  Jung Sunwoo; Yu Kyong Kim; Yewon Choi; Kyung-Sang Yu; Heesook Nam; Young Lag Cho; Seonghae Yoon; Jae-Yong Chung
Journal:  Drug Des Devel Ther       Date:  2018-06-11       Impact factor: 4.162

6.  Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model.

Authors:  Xingyi Qu; Xingchen Bian; Yuancheng Chen; Jiali Hu; Xiaolan Huang; Yu Wang; Yaxin Fan; Hailan Wu; Xin Li; Yi Li; Beining Guo; Xiaofen Liu; Jing Zhang
Journal:  Molecules       Date:  2022-02-06       Impact factor: 4.411

7.  Nanobiotic formulations as promising advances for combating MRSA resistance: susceptibilities and post-antibiotic effects of clindamycin, doxycycline, and linezolid.

Authors:  Mennatallah A Mohamed; Maha Nasr; Walid F Elkhatib; Wafaa N Eltayeb; Aliaa A Elshamy; Gharieb S El-Sayyad
Journal:  RSC Adv       Date:  2021-12-13       Impact factor: 4.036

8.  Novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogs as antibacterial agents: a structural activity relationship.

Authors:  Warda A Hussin; Mohamed A Ismail; Wael M El-Sayed
Journal:  Drug Des Devel Ther       Date:  2013-03-22       Impact factor: 4.162

9.  Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy.

Authors:  Naohito Shirai; Mitsushige Sugimoto; Chise Kodaira; Masafumi Nishino; Mutsuhiro Ikuma; Masayoshi Kajimura; Kyoichi Ohashi; Takashi Ishizaki; Akira Hishida; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2007-06-13       Impact factor: 3.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.